Jun 26, 2026
16 MIN READ

Wegovy First Month Results: What to Expect Week by Week

Your first month on semaglutide brings measurable changes in hunger signals and early weight loss. Understand the week-by-week timeline so you can track your progress and adjust expectations as your body adapts to GLP-1 therapy.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 26, 2026
16 MIN READ

wegovy first month results: what to expect week by week — PlexusDx GLP-1 education

Last reviewed: June 26, 2026

Last updated: June 26, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by activating GLP-1 receptors in your brain and gut, which regulate appetite and blood sugar within days of your first dose. Most patients notice shifts in how food tastes and feels satisfying by the end of week one, though weight loss typically becomes visible around week two or three. PlexusDx offers compounded semaglutide injections starting at $149 per month, allowing you to experience these early changes without the markup of brand-name Wegovy.

Week One: Initial Appetite Suppression Begins

During your first seven days on semaglutide injection, your body is establishing new signaling patterns between your GLP-1 receptors and your central nervous system. Most users report a subtle but noticeable reduction in the urge to snack, especially on foods high in sugar or fat. Some people feel slightly fuller after smaller meals, though this effect is often mild enough that daily life feels normal.

Mild nausea affects roughly 20-30% of new users in week one, typically appearing 1-2 hours after eating and resolving within a few hours. This sensation is temporary and often signals that the medication is working—your stomach is slowing its emptying rate, which is the intended therapeutic effect. Staying hydrated, eating bland foods, and consuming smaller portions can minimize discomfort during this phase.

You may also notice that your relationship with certain foods changes. Beverages high in sugar or rich desserts may suddenly taste too sweet, and this sensory shift happens independently of weight loss. This is part of how semaglutide rewires reward pathways in your brain's appetite control centers.

Week Two: Weight Loss Becomes Measurable

By day 10-14, your first meaningful weight loss typically appears on the scale, ranging from 1-3 pounds depending on your starting point and adherence to portion control. This early loss includes water weight and glycogen depletion, but it also reflects genuine fat mobilization as your body shifts toward burning stored energy. The psychological boost of seeing early results motivates many patients to stay consistent with their dosing schedule.

Appetite suppression deepens in week two for most users, and food cravings—especially for processed snacks—often fade significantly. You may find that you feel satisfied with half your normal portion size, or that you simply forget to eat lunch because hunger signals aren't compelling you to the kitchen. Energy levels often stabilize by mid-week two, after any initial dizziness or mild fatigue resolves.

Some users experience constipation during this phase as a direct result of reduced calorie intake and slower gastric motility. Increasing fiber gradually, drinking extra water, and maintaining light physical activity can address this common side effect. GLP-1 medications do not cause constipation as a direct pharmacologic effect—rather, eating less naturally reduces bowel movement frequency unless you actively compensate.

Week Three and Four: Compound Effects Build

The third and fourth weeks typically bring cumulative results as your dose adjustment window closes and your body fully adapts to semaglutide. Total weight loss by the end of month one often ranges from 3-7 pounds, with individual variation based on starting metabolic rate, baseline activity level, and dietary adherence. More importantly, the behavioral shift—eating less without constant willpower—becomes your new normal rather than a temporary change.

Taste changes may intensify in week three, with some users reporting that previously favorite foods taste off-putting or one-dimensional. This is a direct effect of GLP-1 signaling in taste-processing regions of your brain, and it represents a genuine reset of your reward-food associations. By week four, most people experience a stable appetite baseline that feels sustainable rather than deprived.

Side effects typically peak during week one and gradually diminish by week four, though some users remain sensitive to nausea if they eat too quickly or consume certain foods. Fatigue from rapid calorie deficit usually resolves by week three as your metabolism adjusts. If nausea or other effects persist beyond week four at baseline doses, PlexusDx recommends discussing timing, food choices, or medication adjustments with your care provider to optimize your experience.

Personalization: Why Your Timeline May Differ

Genetic variation in your GLP-1 receptor structure and your body's peptide-pathway sensitivity explain why some patients experience dramatic appetite suppression in week one while others need three weeks to notice a difference. The PlexusDx Precision Peptide Genetic Test examines your variants in GLP1R, GIPR, FTO, and MC4R genes to map how your body's 49 appetite-regulating peptides respond to semaglutide therapy. This testing helps predict your optimal response trajectory and informs dosing strategy.

Your starting dose with PlexusDx begins at the lowest clinical level and increases based on tolerance and efficacy, not calendar weeks. Some patients reach meaningful appetite suppression at 0.25mg, while others require titration to 0.5mg or 1.0mg before noticing strong effects. This individualized approach—combined with flat monthly pricing that doesn't increase with dose—ensures you pay one transparent rate while your therapy scales to your body's needs.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Should I expect weight loss in my first week on semaglutide?

Weight loss in week one is unlikely because your body is establishing metabolic changes and appetite suppression first. Most patients see their first measurable weight loss between days 10-14, while appetite reduction often begins within 3-7 days. Focusing on appetite changes rather than scale changes during week one helps you track progress accurately.

Is nausea during week one a sign the medication isn't right for me?

Mild nausea in the first week affects 20-30% of users and typically resolves by week three as your stomach adapts to slower emptying. This is a known, self-limited side effect of GLP-1 activation, not a sign of intolerance. Eating smaller meals more slowly, avoiding sugar and high-fat foods, and staying hydrated reduce nausea severity significantly.

How much does semaglutide injection cost at PlexusDx, and does price change with my dose?

PlexusDx compounded semaglutide injection costs $149 per month at the lowest tier, with no increase as your dose is adjusted upward. Your dose may need to go up. Your price won't. All injections are prepared by licensed 503A compounding pharmacies and are HSA/FSA eligible, making consistent, transparent pricing available in all 50 states.

What if I experience strong nausea or other side effects in my first month?

Persistent nausea, severe fatigue, or other concerning effects warrant a conversation with your PlexusDx care team, who can recommend adjustments to meal timing, food composition, or dosing schedule. Some side effects resolve with simple behavioral changes—such as eating protein-forward meals or spreading food intake across more frequent, smaller portions—while others may require pausing dose increases temporarily.

Can the PlexusDx genetic test predict how quickly I'll lose weight on semaglutide?

The Precision Peptide Genetic Test ($99 after your first month) identifies your variants in GLP1R, GIPR, FTO, and MC4R, which influence your appetite-suppression response and weight-loss trajectory. While genetics don't predict exact pounds lost, they indicate whether you're likely a rapid responder, moderate responder, or patient who benefits from combination therapy or longer titration—helping PlexusDx personalize your protocol for optimal results.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves